Synthesis, molecular modeling, and K+ channel-blocking activity of dequalinium analogues having semirigid linkers

被引:24
|
作者
Rosa, JC
Galanakis, D
Ganellin, CR
Dunn, PM
机构
[1] UNIV LONDON UNIV COLL,DEPT CHEM,LONDON WC1E 6BT,ENGLAND
[2] UNIV LONDON UNIV COLL,DEPT PHARMACOL,LONDON WC1E 6BT,ENGLAND
关键词
D O I
10.1021/jm950884a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dequalinium [1,1'-(decane-1,10-diyl)bis(2-methyl-4-aminoquinolinium)] is an effective blocker of the small conductance Ca2+-activated K+ channel. It has been shown that the number of methylene groups in the alkyl chain linking the two quinolinium rings of this type of molecule is not critical for activity. To further investigate the role of the linker, analogues of dequalinium have been synthesized, in which the alkyl chain has been replaced by CH(2)XCH(2) where X is a rigid or semirigid group containing aromatic rings. The compounds have been tested for blockade of the slow after-hyperpolarization on rat sympathetic neurons. The most potent compounds have X = phenanthryl, fluorenyl, cis-stilbene, and C6H4(CH2)(n)C6H4, where n = 0-4. The conformational preferences of the compounds were investigated using the XED/COSMIC molecular modeling system. Although there is some dependence of the potency of the analogue on the conformational properties of the linker (X), overall, X groups having substantial structural differences are tolerated. It seems that X provides a support for the two quinolinium groups and does not interact with the channel directly. The intramolecular separation between the quinolinium rings, which is provided by rigid groups X, is not critical for activity; this may be attributed to the residual conformational mobility of the heterocycles and to the extensive delocalization of the positive charge. These two factors may permit favorable contacts between the quinolinium groups and the channel over a range of intramolecular separations.
引用
收藏
页码:4247 / 4254
页数:8
相关论文
共 50 条
  • [31] Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity
    Ismail, Mohamed A. H.
    Lehmann, Jochen
    Abou El Ella, Dalal A.
    Albohy, Amgad
    Abouzid, Khaled A. M.
    MEDICINAL CHEMISTRY RESEARCH, 2009, 18 (09) : 725 - 744
  • [32] Chiral Bistacrine Analogues: Synthesis, Cholinesterase Inhibitory Activity and a Molecular Modeling Approach
    Lopes, Joao P. B.
    da Costa, Jessie S.
    Ceschi, Marco A.
    Goncalves, Carlos A. S.
    Konrath, Eduardo L.
    Karl, Ana L. M.
    Guedes, Isabella A.
    Dardenne, Laurent E.
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2017, 28 (11) : 2218 - 2228
  • [33] Synthesis, molecular modeling, DFT studies, and enantioseparation of tetrahydro-4H-chromene derivatives with calcium channel blocking activity
    Aslan, Ebru Kocak
    Karaguzel, Ayse
    Lam, Kevin
    Dengiz, Cagatay
    Huang, Sun
    Burk, Ryan Jacob
    Salehi, Reza
    Sajeevan, Siddharth Jaya J.
    Zamponi, Gerald W.
    Wolber, Gerhard
    Armstrong, Daniel W.
    Gunduz, Miyase Gozde
    JOURNAL OF MOLECULAR STRUCTURE, 2025, 1330
  • [34] Synthesis and pharmacological testing of dequalinium analogue as blockers of the apamin-sensitive Ca2+-activated K+ channel: Variation of the length of the alkylene chain
    Galanakis, D
    Ganellin, CR
    Malik, S
    Dunn, PM
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (18) : 3592 - 3595
  • [35] Interaction between barium ions and a cloned K+ channel pore -: A molecular modeling study.
    Yamamoto, D
    Sohma, Y
    Imai, Y
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 348A - 348A
  • [36] Synthesis and biological activity of novel 2-(α-alkoxyimino)benzylpyridine derivatives as K+ channel openers
    Maekawa, T
    Yamamoto, S
    Igata, Y
    Ikeda, S
    Watanabe, T
    Shiraishi, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1997, 45 (12) : 1994 - 2004
  • [37] Synthesis and biological activity of novel 1,3-benzoxazine derivatives as K+ channel openers
    Yamamoto, S
    Hashiguchi, S
    Miki, S
    Igata, Y
    Watanabe, T
    Shiraishi, M
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1996, 44 (04) : 734 - 745
  • [38] SYNTHESIS, MUSCARINIC BLOCKING ACTIVITY AND MOLECULAR MODELING STUDIES OF 4-DAMP-RELATED COMPOUNDS
    RECANATINI, M
    TUMIATTI, V
    BUDRIESI, R
    CHIARINI, A
    SABATINO, P
    BOLOGNESI, ML
    MELCHIORRE, C
    BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (03) : 267 - 277
  • [39] Synthesis, antiplatelet aggregation activity, and molecular modeling study of novel substituted-piperazine analogues
    Khairia M. Youssef
    Mohamed A. Al-Omar
    Hussein I. El-Subbagh
    Laila A. Abou-zeid
    Abdel-Galil M. Abdel-Gader
    Nadia G. Haress
    Ali S. Al-Tuwaijri
    Medicinal Chemistry Research, 2011, 20 : 898 - 911
  • [40] Synthesis, antiplatelet aggregation activity, and molecular modeling study of novel substituted-piperazine analogues
    Youssef, Khairia M.
    Al-Omar, Mohamed A.
    El-Subbagh, Hussein I.
    Abou-Zeid, Laila A.
    Abdel-Gader, Abdel-Galil M.
    Haress, Nadia G.
    Al-Tuwaijri, Ali S.
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (07) : 898 - 911